Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07637695Completed
Randomised trial in incontinence-associated dermatitis (IAD) (2 arms), sponsored by Taoyuan Armed Forces General Hospital. Primary endpoint: Change in Incontinence-Associated Dermatitis Severity Score at Day 14. Started Jan 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07637695.